Low-density lipoprotein-cholesterol (LDL-C) is the "bad" cholesterol, and despite many drugs including statins available to doctors, patients often have trouble reducing their blood level of LCL-C.
Sanofi and Regeneron presented data at The American College of Cardiology Meeting on 26th March 2012, showing an impressive reduction using their new antibody treatment known as SAR236553/REGN727. The human antibody is administered subcutaneously and targets PCSK9 (proprotein convertase
Cara Mendapatkan Gems COC Gratis 2017
7 years ago
Post a Comment